We are live on ! Find out more
LPCN icon

Lipocine
LPCN

19 hedge funds and large institutions have $29.7M invested in Lipocine in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

59% more capital invested

Capital invested by funds: $18.7M → $29.7M (+$11.1M)

14% less funds holding

Funds holding: 22 → 19 (-3)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Holders
19
Holders Change
-3
Holders Change %
-13.64%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
3
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CAM
Cormorant Asset Management
Massachusetts
+$4.26M
2
JGC
J. Goldman & Co
New York
+$576K
3
Ameriprise
Ameriprise
Minnesota
+$512K
4
Renaissance Technologies
Renaissance Technologies
New York
+$159K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$136K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$652K
2
ARTA
A.R.T. Advisors
New York
-$71K
3
BBA
Baker Bros. Advisors
New York
-$69.3K
4
Morgan Stanley
Morgan Stanley
New York
-$28K
5
Citigroup
Citigroup
New York
-$26K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
– -$2K -21 Closed
1
2

LPCN Hedge Fund Activity: Q1 2015 in Review

19 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q1 2015, worth a combined $29.7M — up 59% from $18.7M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of LPCN and 5 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 5 added.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $4.26M. The largest seller was Millennium Management, exiting entirely with an estimated $652K sold.

  • 19 institutional investors held Lipocine (LPCN) as of Q1 2015, down from 22 in Q4 2014.
  • Funds reported $29.7M of Lipocine stock for Q1 2015, up 59% quarter-over-quarter.
  • 5 funds opened new Lipocine positions in Q1 2015 and 8 closed out, a net change of -3 holders.
  • The largest Lipocine buyer in Q1 2015 was Cormorant Asset Management, an estimated $4.26M added.
  • The largest Lipocine seller in Q1 2015 was Millennium Management, an estimated $652K sold.

Based on aggregated 13F filings for Q1 2015.